Barbiturate Toxicity
- PMID: 29763050
- Bookshelf ID: NBK499875
Barbiturate Toxicity
Excerpt
Barbiturates are sedative-hypnotic drugs. They are derivates of barbituric acid and were introduced clinically in the early 1900s. Over the past 120 years, barbiturates have been used for a broad spectrum of indications, including insomnia, psychiatric disorders, anesthesia, alcohol withdrawal, seizures, and elevated intracranial pressure. These drugs have a narrow therapeutic index, are highly addictive, and carry a high risk for toxicity. Thus, the use of these drugs has declined mainly in the last several decades in favor of agents with more favorable safety profiles. Despite a lower rate of barbiturate utilization overall, barbiturate toxicity is still a prevalent cause of significant morbidity and mortality that requires prompt and effective care to mitigate.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
- Continuing Education Activity
- Introduction
- Etiology
- Epidemiology
- Pathophysiology
- Toxicokinetics
- History and Physical
- Evaluation
- Treatment / Management
- Differential Diagnosis
- Prognosis
- Complications
- Consultations
- Deterrence and Patient Education
- Enhancing Healthcare Team Outcomes
- Review Questions
- References
References
-
- Coupey SM. Barbiturates. Pediatr Rev. 1997 Aug;18(8):260-4; quiz 265. - PubMed
-
- Mactier R, Laliberté M, Mardini J, Ghannoum M, Lavergne V, Gosselin S, Hoffman RS, Nolin TD, EXTRIP Workgroup Extracorporeal treatment for barbiturate poisoning: recommendations from the EXTRIP Workgroup. Am J Kidney Dis. 2014 Sep;64(3):347-58. - PubMed
-
- Sato M, Tanaka S, Suzuki K, Kohama A, Fujii C. Complications associated with barbiturate therapy. Resuscitation. 1989 Jun;17(3):233-41. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous